Business
Announcement on Receiving Letter of Regulation from Shanghai Stock Exchange on Information Disclosure of the Company's Report for Q3 2024
Announcement on Receiving Letter of Regulation from Shanghai Stock Exchange on Information Disclosure of the Company's Report for Q3 2024
About this update from Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A
Announcement on Receiving Letter of Regulation from Shanghai Stock Exchange on Information Disclosure of the Company's Report for Q3 2024 The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment